SGMO Sangamo Therapeutics, Inc.
Price Chart
Executive Summary
Sangamo Therapeutics announced it will release its Q4 and full-year 2025 financial results on March 30, 2026, followed by a conference call to review the results and provide business updates. The press release contains no actual financial data, only logistical details about the earnings announcement.
Actionable Insight
Traders should monitor the March 30 earnings call for updates on revenue, R&D progress, cash runway, and pipeline developments, which could move the stock given the company's small market cap ($121M).
Key Facts
- Sangamo Therapeutics will release Q4 and full-year 2025 financial results after market close on March 30, 2026.
- A conference call is scheduled for 4:30 p.m. Eastern on the same day to discuss results and business updates.
- No financial figures, guidance, or operational updates were disclosed in this press release.
Financial Impact
No financial data disclosed — impact will depend on actual earnings release
Risk Factors
- High volatility expected post-earnings due to small market cap and lack of current revenue-generating products.
- No financial or operational metrics provided in this release — actual results may differ significantly from expectations.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259419 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 29, 2026
6w ago
|
8-K
| $0.1300 $0.2000 | ▼ −53.85% | ▼ −48.39% | $0.1500 (−15.38%) |
|
Apr 21, 2026
7w ago
|
Insider Cluster
| $0.2600 $0.1300 | ▼ −50.00% | ▼ −54.91% | $0.1500 (−42.31%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $0.2500 $0.1387 | ▼ −44.52% | ▼ −53.94% | $0.1500 (−40.00%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $0.3300 $0.2700 | ▼ −18.18% | ▼ −27.50% | $0.1500 (−54.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access